Publication date: Jul 07, 2025
The mice receiving the special copper supplement, however, did not develop movement problems. The results were beyond our expectations, said Prof. Fox Foundation), the mice receiving only the placebo saw a decline in their motor symptoms. One group was treated with a special copper supplement for three months, while the other received a placebo. Throughout the study (which was partly funded by the Michael J.
| Concepts | Keywords |
|---|---|
| Decade | Brain |
| Parkinsons | Copper |
| Professor | Disease |
| Proteincalled | Double |
| Faulty | |
| Motor | |
| Parkinson | |
| Parkinsons | |
| Progression | |
| Slow | |
| Sod1 | |
| Symptoms | |
| Treating | |
| Treatment | |
| Treatments |
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | Isoxaflutole |
| disease | MESH | causes |
| disease | MESH | tremors |
| drug | DRUGBANK | Dopamine |
| pathway | KEGG | Parkinson disease |
| disease | MESH | Parkinson disease |
| pathway | REACTOME | Release |
| drug | DRUGBANK | Copper |
| disease | MESH | dementia |
| drug | DRUGBANK | Spinosad |
Original Article
(Visited 5 times, 1 visits today)